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The functions ofresident macrophages (MO)' in hematopoietic and lymphoid
organs are poorly understood. In severalspecies, in situ immunocytochemical staining
with MO-specific mAbs has demonstrated that these tissues contain large numbers
ofstromal MO, even in the absence of overt inflammation or immune stimulation
(1-6). We and others have previously speculated that stromal MO may perform di-
verselocal homeostaticfunctions, includingregulation ofgrowth, differentiation and
movement ofhematopoietic and lymphoid cells (7, 8). Our experimental approach
has been to isolate the relevant MOpopulations anddetermine whether they possess
novel features that could be involved in cellular interactions .
We have focused on murine bonemarrow, since this tissue contains an arborizing
network ofstromal MO that establish intimate adhesive contacts with proliferating
erythroid andmyeloidcells (1, 7). Aftertheir isolation, themajority ofresident bone
marrow MO express a novel receptor, sheep erythrocyte receptor (SER), which
mediates the binding, but not ingestion, ofunopsonized sheep erythrocytes (E) (9).
Since it is possible that SER normally interacts with a homologous ligand on mouse
bone marrow cells it was ofinterest to characterize its properties and distribution.
SER is a divalent cation-independent, lectin-like hemagglutinin that recognizes
sialylated glycoconjugates on the erythrocyte surface. Its properties are similar to
the "ganglioside receptor" on rat MO described by Riedl and colleagues (10). In ad-
dition to resident bone marrow MO, the receptor is expressed at high levels on iso-
lated stromal lymph node MObut it is low or undetectable on monocytes or perito-
neal, pleural, and bronchoalveolar MO. These features indicate that SER may be
involved in interactions ofstromal MO with ligands on neighboringcells orextracel-
lular matrix components .
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To understand the nature and functions of SER, it would clearly be advantageous
to raise an mAb to the receptor. The recent observation that high levels ofSER are
induced on peritoneal MO cultivated in mouse serum provided us with a suitable
source ofantigenic material and a rapid method for screening inhibitory mAbs (11).
In this paper we describe the isolation of mAb SER4, characterize the molecular
nature of SER, and determine its distribution on MO in various tissues.
Materials and Methods
Animals.
￿
Female C57B1/6 mice were bred at the Sir William Dunn School of Pathology,
Oxford University and used at 2-4 mo. Specific pathogen-free female AO rats were bred
in the MRC Cellular Immunology Unit, Oxford University and used at 3-6 mo.
Reagents.
￿
M1/9.3, a rat pan antileukocyte common (LC) antigen (Ag) mAb (12), was
provided by Dr. R. S. Steinman, The Rockefeller University (New York, NY), MOMA-1,
a rat mAb that recognizes marginal metallophils of the spleen (13), was kindly supplied by
Dr. G. Kraal, Free University, Amsterdam, The Netherlands. 1A10, a rat mAb directed to
an Ag on guinea pig neutrophils (14) from Dr. H. Rosen in our laboratory was used as a
negative control in immunoprecipitation and immunocytochemistry experiments. From Sigma
Chemical Co. (Poole, United Kingdom) we obtained BSA, glucose oxidase, iodoacetamide,
PMSF, EDTA, pepstatin, and soybean trypsin inhibitor. Lactoperoxidase was obtained from
Boehringer Corp., Lewes, United Kingdom. FCS was purchased from Imperial Laborato-
ries, Salisbury, United Kingdom. Iscove's modification of Dulbecco's Medium and Hepes
buffer were obtained from Gibco Laboratories, Paisley, Scotland. Carrier-free Nai25I,
["S]methionine (code SJ .204) and ["S]cysteine (code SJ.232) were purchased from Amer-
sham International PLC, Amersham, UK. Protein A-Sepharose was from Pharmacia Fine
Chemicals, Hounslow, UK.
Cells.
￿
Thioglycollate-elicited peritoneal MO (TPM) were obtained 4 d afterintraperitoneal
injection of 1 ml Brewer's complete thioglycollate broth. Resident bone marrow MO were
isolated by collagenase digestion offemoral bone marrow plugs, selective adherence ofpurified
clusters to glass coverslips, and removal of attached hematopoietic cells (7).
Sheep Erythrocyte RosettingAssays.
￿
These were carried out as described previously (11). Briefly,
2 x 104 TPM were added to each well of a 96-well tissue culture microtiter plate (Falcon
Labware, Lincoln Park, NJ) and cultured for 3-4 d in 100 pl DME containing 15% mouse
serum prepared as previously described (11). After washingwith DME + 0.1% BSA, 20 mM
Hepes, sheep E were added at 0.5% vol/vol and the plates incubated at 37°C for 30 min.
Nonadherent sheep E were removed by repeated washing with medium and the percentage
of MO binding >4 E was determined. In some experiments, rosetting assays were carried
out with Mo on coverslips (9).
Production of mAb SER-4.
￿
AO rats were immunized intramuscularly three times at 10-d
intervals with 107 TPM that had been cultured for 3 d in 150 7o mouse serum to induce SER
(11). Before injection, TPM were scraped from dishes and washed three times in PBS to re-
move mouse serum. The first injection was with complete and subsequent injections with
IFA. Rats were boosted intravenously with 5 x 106 mouse serum-induced TPM 3 d before
fusion ofspleen cells with the rat myeloma line Y3 (15). Hybridoma supernatants were screened
for theirability to prevent rosette formation to mouse serum-induced TPM using the micro-
titer assay described above. One positive supernatant was identified from a total of >2,500
in four separate fusions and the hybridoma, designated SER4, was cloned three times by
limiting dilution. The isotype of mAb SER4 was determined by Ouchterlony gel diffusion
analysis using antisera directed against rat IgG subclasses, kindly supplied by Dr. H. Bazin
(Catholic University, Louvain, Belgium).
Purification ofIgG andIts Fragmentsfrom SER-4.
￿
SER4 was grown as an ascites in pristane-
primed AO rats, and the IgG was purified by sodium sulphate precipitation and anion-exchange
chromatography using DEAE-Sephacel (Pharmacia Fine Chemicals). F(ab')2 and Fab frag-
ments were prepared as described by Rousseaux et al. for rat IgG2a (16). Purity of IgG,
F(ab')2 and Fab was >95% when assessed by SDS-PAGE and Coomassie Brilliant BlueCROCKER AND GORDON
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staining, using 10% acrylamide gels under reducing and nonreducing conditions. Protein
concentrations were determined by measuring absorbance at 280 nM, assuming an extinc-
tion coefficient of 1.4.
Comparison ofSER Expression with SER-4 Ag .
￿
TPM were plated at 105/well in 96-well tissue
culture microtiter plates in the defined serum-free medium, HB102 (New England Nuclear,
Boston, MA) and allowed to adhere for 90 min. This and subsequent incubations were at
37°C and 5% C02 in a fully humidified incubator. Supernatants were removed and replaced
with HB102 medium containing mouse serum at 20, 5, or 0% . SER assays were carried out
in quadruplicate on days 0, 1, 2, and 4. Rosettes were fixed in 0.125% glutaraldehyde for
10 min and permeabilized in methanol for 30 min. The relative numbers of sheep E bound/well
were determined by measuring the pseudoperoxidase activity of hemoglobin (17), as follows.
PBS containing 10 mM imidazole, 0.5 mg/ml diaminobenzidine (DAB), and 0.02% H202
(pH 7.4), was added to wells. After 1 h at room temperature absorbance ofthe reaction product
was measured at 410 nm on a Titertek plate reader (Dynatech Laboratories, Inc., Alexan-
dria, VA).
To determine the number of cells in each well, the nuclei of methanol-fixed TPM in sepa-
rate wells were stained for 1 min with 1% crystal violet in 70% methanol, followed by exten-
sive rinsing with tap water. The absorbance at 570 nm was determined on the Titertek plate
reader and converted to cell number using a linear standard curve, obtained by plating serial
dilutions of TPM. The relative number of sheep E bound per MO was calculated and ex-
pressed as an E/MO index = OD (DAB)/OD (Crystal violet).
The remaining wells on each row were used for determination of SER4 Ag site number.
Wells were rinsed with FCS, air dried, and the plates were stored desiccated at -20°C. Im-
mediately before assay, TPM were fixed for 10 min in methanol and nonspecific binding
sites blocked by incubation in 10% rat serum for 30 min. Wells were .incubated for 60 min
at 4°C with 50 /Al of a predetermined saturating concentration (10 Wg/ml) of 1251-SER4 Fab,
specific activity 1.3 fACi/lAg, labeled by the chloramine T method (18). Specific binding was
determined by subtracting counts from separate wells that had been preincubated with 30
Rg/ml unlabeled SER4 IgG before addition of 1211-SER-4 Fab. As an internal control for
site number analysis, binding assays were also carried out with '25I-Fab fragments of the anti-
CR3 mAb, 5C6, provided by Dr. H. Rosen (19). Bound radioactivity was solubilized in 0.5%
NaCH and counted in a Packard 5210 gamma counter.
Immunocytochemistry.
￿
In preliminary experiments the antigenic determinant recognized
by mAb SER4 was destroyed by the fixatives glutaraldehyde and paraformaldehyde but not
ethanol, methanol, or acetone. 7-AM cryostat sections were therefore fixed for 10 min in ace-
tone at room temperature and stained with a 1 :5 dilution ofhybridoma tissue culture super-
natant using an avidin-biotin-peroxidase detection kit (Vectastain; Vector Laboratories, Peter-
borough, UK). Negative controls included omission of first antibody and use of rat mAbs
directed to unrelated Ag.
Immunoprecipitation.
￿
10' TPM were cultured for 2 d in 10-cm diameter tissue culture petri
dishes at a concentration of 106/ml in DME + 10% mouse serum. For metabolic labeling,
the medium was changed to methionine- and cysteine-free Eagle's medium with 10% mouse
serum that had been desalted into the same medium using PD-10 columns (Pharmacia Fine
Chemicals). [35S]Methionine and ["S]cysteine were each added at 25 ACi/ml, final concen-
tration, and the cells were incubated for a further 16 h. For surface labeling, TPM, adherent
to 10-cm diameter dishes, were iodinated by the lactoperoxidase-glucose oxidase method for
30 min at 4°C (20). After either method of labeling, TPM were washed extensively and solu-
bilized in 10 mM Tris lysis buffer, pH 8.0, containing 150 mM NaCl, 2% NP-40, 2 mM
PMSF, 5 mM EDTA, 5 mM iodoacetamide, 100 FLg/ml soybean trypsin inhibitor, 1 ug/ml
pepstatin, and 0.5% BSA. Nuclei and other insoluble materials were removed by centrifuga-
tion at 10,000 g and immunoprecipitations carried out as described (19). The samples were
electrophoresed on 6.5% polyacrylamide gels according to Laemmli (21). '4C-methylated
protein molecular weight markers (code CFA 626) were obtained from Amersham Interna-
tional PLC .
Western Blots.
￿
TPM were cultured for 3 d and lysates were prepared as described above.
Spleen, mesenteric lymph nodes, thymus, and femoral bone marrow plugs were obtained1336
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from a single mouse and added to 1 ml of 10 mM Tris, pH 8.0, containing 150 mM NaCl
and protease inhibitors. The tissues were disrupted using an electrically driven homogenizer
(Polytron; Kinematica GmbH, Lucerne, Switzerland) and solubilized by addition ofan equal
volume of nonreducing 2 x SDS-PAGE sample buffer. Reduction with (3-mercaptoethanol
resulted in loss of antigenic activity. After removal of insoluble material by centrifugation
at 10,000 g, 35 ul of the lysates were electrophoresed on 6.5% polyacrylamide gels. Proteins
were transferred to nitrocellulose as described (22) and probed with 0.5 t~g/ml "'I-SER-4
IgG, prepared by the chloramine T method (18). Specificity was determined by comparing
the signals obtained in the presence or absence of 100-fold excess of unlabeled SER4 IgG.
Results
Isolation of an mAb Directed to SER.
￿
To obtain an mAb to SER, our strategy was
to immunize rats,wlth mouse serum-induced TPM expressing high levels of SER,
as determinedby sheep E binding, and then to screen hybridoma supernatants for
their ability to block sheep E binding to induced TPM (11). From a total of four
fusions, one positive hybridoma was identified and designated SER-4. Tissue cul-
ture supernatant from SER-4 was able to completely inhibit binding of sheep E to
mouse serum-induced TPM (Fig. 1). Complete inhibition of sheep E binding was
also observed with resident bone marrow MO on which the hemagglutinin was first
described (not shown). Inhibition of SER by SER-4 supernatant was not accompa-
nied by visible signs of toxicity or changes in morphology.
SER-4 was cloned three times by limiting dilution and was found to secrete an
mAb of the rat IgG2a subclass by Ouchterlony analysis. After purification, the in-
tact immunoglobulin was able to inhibit sheep E binding completely at ti 1 /Ag/ml
(Fig. 2). In comparison, F(ab')2 fragments of SER4 mAb gave a maximum of only
50-60% inhibition, while Fab fragments had no effect on rosetting, even at concen-
trations up to 100 Ftg/ml (Fig. 2). The failure of Fab to inhibit binding of sheep E
was not due to its lower avidity, since at 40 p,g/ml it completely inhibited binding
of a saturating concontration (1 hg/ml) of SER4 IgG to TPM. In addition, 125I-
SER-4 Fab bound to induced TPM in a specific and saturable manner, with max-
imal binding at 10 hg/ml (not shown).
Comparison ofExpression ofSER with theSER-4Ag
￿
Our previous studies have demon-
strated that the in vitro expression of SER on TPM can be regulated reversibly by
mouse serum in a dose-dependent fashion (11) . It was therefore of interest to com-
pare the binding of sheep E with expression of the SER-4 Ag by TPM cultured in
a range of mouse serum concentrations. Antigenic site number analysis was carried
out by direct binding assay with "5I-SER-4 Fab on methanol-fixed TPM. This
measures the total amount ofSER-4 Ag, both intra- and extracellular. It can be seen
in Fig. 3 that expressionof SER and the SER-4Ag were closely correlated throughout
the course of the experiment. At the outset of culture, TPM bound an average of
4 x 104 SER4 Fab molecules/cell and there was negligible binding of sheep E. The
highest levels ofboth SER-4 Ag and SER expression were observed on day 2 of cul-
ture in 20% mouse serum. At this time TPM bound an average of -10' SER-4 Fab
molecules/cell, representing a 25-fold increase in antigenic site number. In compar-
ison, levels of SER activity (sheep E binding) increased -10-fold. As an internal
control for the site number analysis, binding assays were also carried out with Fab
fragments of 5C6 anti CR3 mAb (19). On day 2, TPM bound on average of 2 x
105 molecules of ' 25I-5C6-Fab, irrespective ofthe concentration of mouse serum usedw
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FIGURE 1 .
￿
Inhibition ofSER by mAb SER-4. Phase contrast micrographs of rosetting assays
with mouseserum-inducedTPM in theabsence (A) or presence (B) of SER-4mAb tissue culture
supernatant . TPM were cultured on glass coverslips for 3d in 15% mouseserum to induceSER.
They were then incubated for 1 h in the presence or absenceofSER-4 mAbtissue culture super-
natant. After extensive washing, sheep Ewere added at 0.5% vol/vol . After 30 min at 37°C un-
bound sheep E were removed and the preparations were fixed in 1% glutaraldehyde before ex-
amination . (A) The majority ofTPM rosette intensely with sheep E. (B) Erythrocyte binding
is completely inhibited after preincubation with SER-4 mAb tissue culture supernatant .
Fab
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FIGURE 2.
￿
Inhibition ofSER
by mAb SER-4 IgG, F(ab')2,
and Fabfragments . TPMwere
induced to expressSERby cul-
ture in 15% mouse serum for
3 d on microtiter plates . Wells
were incubated for 1 h with
threefold serial dilutions ofIgG,
F(ab')2, or Fab, washed exten-
sively, and assayed for sheep E
binding. The data show mean
values ofduplicate wells. Similar
results were obtained in three
independent experiments .1338
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Comparison ofSER
expression with SER-4 Ag in
cultured TPM. TPMwere cul-
tured for up to 4don microtiter
plates in the presence of 20, 5,
or 0% mouseserum. Thelevel
SER-4
￿
ofSER (left) is expressed as the
sheep E binding index. This is
2o
￿
a measure of the average num-
berof E bound perMO, deter-
mined by optical density. ForE,
the pseudoperoxidase activity of
hemoglobin was measured at
410 nm,usingDABas substrate,
andthe numberof MO per well
wasmeasured at 570 nm after
nuclear staining with crystal
violet. The sheep E binding
index wascalculated as OD41o/
OD57o. The level of SER4 Ag
(right) wasdetermined by direct
radioimmune binding assay,
1 2 3 n usinfasaturatingconcentration
of I SI-SER4 Fab. Measure-
ments of SER and SER4 Ag
were carried out at the begin-
ning of culture and on days 1,
2, and 4. Serum was removed
from all remainingwells on day
2 in orderto reverse the expres-
sion of SER.
for culture. This is in agreement with previous estimates of CR3 site number on
MO (23). Afterremovalof serum after48 h, thelevels of SER4 Ag and SER declined
in parallel. These results support the notion that the Ag recognized by SER-4 mAb
is either closely related to, or identical with, SER.
Characterization of the Antigen Recognized by mAb SER-4.
￿
After metabolic labeling
of mouse serum-induced TPM with a mixture of [35S]methionine and ["S]cysteine,
mAb SER4 was found to immunoprecipitate two species ofAg determined by SDS-
PAGE not seen with control mAb 1A10 (Fig. 4A). Under reducing conditions there
was a major band with apparent Mr of -185 x 103 and a minor band at -175 x
103. Under nonreducing conditions, the apparent M r of each band was decreased
by -15 x 103 indicating the presence of one or more intrachain disulphide bonds.
After t25I surface labeling of mouse serum-induced TPM, mAb SER-4
specifically immunoprecipitated a single species of Ag by SDS-PAGE, with an ap-
parent Mr of -185 x 103 (reduced) (Fig. 4 B) or -170 x 103 (nonreduced) (not
shown). Since the lower Mr species observed after metabolic labeling was not de-
tected with surface labeling, it is likely to be an incompletely processed form of the
molecule that is absent from the plasma membrane.
To determine whether the SER4 Ag was one of the forms of the LC Ag (24) we
carriedout immunoprecipitations with apan anti-LC mAb, M1/9 .3 (12). Following
surface labeling with 1211, the LC Ag ran under reducing conditions on SDS-PAGE
as abroad band with a Mr ranging from 155 to 180 x 103. This was clearly distinctCROCKER AND GORDON
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FIGURE 4 .
￿
6.5% SDS-PAGE of
(A) [35S]methionine and [35S]-
cysteine-labeledTPM cultured
in 15% mouse serum and (B)
125I-labeled TPM cultured in
15% mouse serum . After
solubilization in 2% NP-40, im-
munoprecipitations were car-
ried out with control mAb,
1A10, or with mAbSER-4 un-
der reducing (R) or non-
reducing (NR)conditions. The
nonspecific band observed at 50
M, after surface iodination
representsheavy chain ofmouse
Ig. IgG isadsorbed from mouse
serum toTPM during culture,
becomes iodinated, and subse-
quently binds proteinASepha-
rose during immunoprecipita-
tion .The positions ofmolecular
weight standards (x 10-3) are
indicated .
from the SER-4 Ag immunoprecipitated from the same lysate and run on the same
gel (Fig . 4 B) . This demonstrates that the SER-4 Ag is not a member of the LC
Ag family.
Distribution ofSER-4Ag In Vioo.
￿
In a previous study it was shown that expression
ofSER, assessed by rosette analysis, was restricted to certainsubpopulations ofstromal
tissue MO, especially those isolated from hematopoietic and lymphoid tissues . It
was therefore important to compare the pattern of SER expression with the immu-
nocytochemical distribution of SER4 Ag in various tissues .
First, in cryostat sections ofbone marrow plugs, mAbSER-4 revealed an arborizing
network of stromal cells that were evenly distributed throughout the tissue (Fig. 5
A) . These cells had the morphological features of resident bonemarrowMO (1, 6-8),
and were intimately associated with hematopoietic cells . Immunofluorescence double-
labeling experiments with the MO-specific mAb, F4/80 (18), confirmed that SER-
4 + cells were also F4/80+ (not shown) . However, bone marrow monocytes, which
label with F4/80, were not stained by SER-4 . The selectivity ofmAbSER4 for the
residentMO population is consistent with previous rosetting experiments in which
the resident MO were shown to be the only bone marrow cells, including mono-
cytes, able to bind sheep erythrocytes (9) .1340
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In lymph nodes, either mesenteric (Fig. 5 B), cervical or popliteal (not shown),
intense staining was observed on stromal MO in the subcapsular sinus and medul-
lary cords, but tingible bodyMO present in follicles were not stained . In some fol-
licles, however, SER-4 revealed a reticular staining pattern within the developing
germinal centers . The anatomical location and appearance of this staining pattern
suggest that follicular dendritic cells may also be SER4+ (25).
In the spleen, strong reactivity was observed on very stellate cells within the inner
region of the marginal zone (Fig . 5 C) . Weaker, but easily detectable staining was
also present on marginal zone and red pulp MO (Fig. 5 C) . Examination under
high power showed that the most strongly staining cells were on the follicular side
of the marginal sinus . They can therefore be identified as marginal metallophils,
a specialized subpopulation of spleen MO (26, 27) . In support of this conclusion,
we found that MOMA-1, a rat mAb that specifically recognizes mouse marginal
metallophils (13), produced a staining pattern in the spleen that was indistinguish-
able from that ofSER-4 (not shown) . In contrast to the other lymphoid tissues, the
thymus showed no detectable staining with SER-4 (not shown) .
In the liver, Kupffer cells were found to stain weakly, but uniformly with SER-4
(Fig . 5 D) . In the lung, the stellate interstitialMO stained strongly with SER-4 and
FIGURE 6 .
￿
Western blots of SER4 Ag ex-
pression in nonreduced lysates of mouse
serum-induced TPM, spleen, lymph nodes,
thymus, and bone marrow. Blots were prepared
from 6 .5 17o gels and probed with 1251-SER4
IgG in the absence or presence (left) panel of
100-fold excess unlabeled SER4 IgG. A specific
band at ti170 x 103Mr can be seen in lysates
ofmouse serum-induced TPM, spleen, lymph
node, and bone marrow, but not thymus . The
weak signal observed in bone marrow lysates
reflects the fact that lysates were normalized
for organ input, rather than cell number. The
positions of molecular weight standards
(x 10-3 ) are indicated .1342
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a subpopulation of bronchoalveolar MO was also positive (not shown). In the skin,
no reactivity was observed on epidermal Langerhans cells, though scattered dermal
histiocytes were strongly positive (not shown). In the small intestine, occasional MO
in the lamina propria were stained and stromal MO underlying the dome epithe-
lium of Peyer's patches were also positive (not shown). In the kidney, virtually no
MO or other cell populations reacted with SER-4 (not shown). Finally, in the brain,
microglia in the white and grey matter were completely negative for SER4. Interest-
ingly, however, the majority of MOB outside the blood brain barrier (28), in the choroid
plexus, pituitary gland, subfornical organ, and leptomeninges, were clearly positive
(not shown).
Nature ofSER-4 Ag in Tissues.
￿
Western blot analyses were carried out to deter-
mine the nature of the Ag recognized by mAb SER-4 in hematopoietic and lym-
phoid tissues (Fig. 6). With nonreduced lysates ofmouse serum-induced TPM, used
as a control, 1251-SER-4 IgG specifically bound a 170-kD molecule (Fig. 6). Indis-
tinguishable bands at 170 kD were seen for spleen, lymph node, and bone marrow,
but no band was visible in the thymus (Fig. 6). The rank order (normalized on an
organ, rather than cell number basis) was lymph node > spleen > bone marrow.
The relative amount of SER-4 Ag for each tissue is therefore in agreement with the
overall intensity of staining observed by immunocytochemistry.
Discussion
In this study we described the isolation and characterization of an mAb directed
to SER, a novel MO receptor that binds unopsonized sheep E via recognition of
sialylated glycoconjugates (9). Our strategy, to screen for mAbs that inhibit receptor
function, is a powerful selection method that has been used previously to isolate
mAbs to FcR, fibronectin receptor, and otheradhesion receptors on MO (19, 29, 30).
Several lines of evidence indicate that the molecule recognized by mAb SER4
is equivalent to SER, defined previously by rosetting studies. First, the time course
of expression of the Ag on peritoneal MO cultured in mouse serum closely parallels
that of SER. Second, the distribution of the Ag in situ is consistent with previous
rosetting studies of SER expression on isolated tissue MO populations (9). Third,
recent experiments in our laboratory indicate that the purified molecule specifically
agglutinates sheep E (Crocker, P., unpublished observations).
It is likely that mAb SER4 is directed close to, but not at, the putative sialic acid
binding site of the receptor, since only 50% inhibition was obtained with F(ab')2
fragments while Fab fragments had no effect on SER function, despite binding effec-
tively to the SER4 Ag. This pattern of inhibition is compatible with steric hindrance
such that the degree of inhibition is proportional to the size of the mAb fragment.
However, we cannot exclude a partial role for MO Fc receptors in mediating the
inhibition by intact IgG.
The molecular properties and tissue distribution of the SER4 Ag suggest that
it is a previously uncharacterized differentiation Ag of mononuclear phagocytes. Im-
munoprecipitation and Western blotting experiments demonstrated that the SER-4
Ag is synthesized by MO as a single-chain plasma membrane protein that on SDS-
PAGE has an apparent Mr of 185 x 103 under reducing conditions and 170 x 103
under nonreducing conditions. Despite the similarity in Mr to the LC Ag family
of molecules, the SER-4 Ag was shown to be distinct from members of this family
expressed on the same MO (24). The SER-4 Ag is of similar Mr to several otherCROCKER AND GORDON
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single chain lectin-like receptors present in eukaryotic cells. Theseinclude the man-
nose receptor (175 kD) and the cation-independent mannose-6-phosphate receptor
(215 kD), both of which are expressed on MO as well as other cell types (31-33).
However, SER can be distinguished from both molecules on the bases of ligand
specificity, behavior on SDS-PAGE, and tissue distribution (31-33).
The SER-4Agwas found to bepresentathigh levels on subpopulations ofstromal
tissue macrophages. The pattern ofexpression was in agreement with earlier sheep
E rosetting assays for SER (9). Thus, in the bone marrow, SER-4 Ag was restricted
to the resident bone marrow MO population, with none being detected on the de-
veloping F4/80+ monocytes. Particularly striking was the high level of expression
bythe majorityofstromal MO in lymph nodes that also rosette intensely with sheep
E (9). The spleen showed amore complex pattern ofreactivity forSER-4, with high
levels observed onlyonmarginal metallophils. Lesser, but clearstainingwas detected
on MO in the red pulp and the outer marginal zone. Since the majority ofstromal
MO isolated from the spleen by collagenase digestion are from the red pulp and
marginal zone (34, 35), the immunocytochemical staining pattern observed in the
present study isconsistent with previous rosetting analyses in which isolated stromal
spleen MO expressed moderate levels of SER (9).
Site number analysis ofSER expression byTPMcultured in mouse serum showed
that an average of up to 106 molecules of SER-4 Ag were expressed per cell. Al-
though N50% ofthis is intracellular (Crocker, P, unpublished observations), it is
clear that when compared with otherwell-characterized plasma membrane receptors
such as mannose receptor, CR3 and FcR, SER is potentially one ofthemosthighly
expressed MO-restricted surface molecules described to date.
How can the heterogeneity ofSER expression on MO populations be explained?
We haverecently demonstrated that the inductionand maintenance ofSERon MO
in vitro is regulated in a dose-dependent manner by a species-restricted activity in
mouse plasma and lymph (11). The activity in plasma had an apparent M, of-70
x 103 by gel filtration and this led us to propose that the heterogeneity ofSER ex-
pression on different MOpopulations could in part beexplainedby the relative con-
centrationofinducingactivity indifferent tissue compartments. In the present study,
clear evidence for this possibility was seen in the central nervous system, where
microgliawithin the blood brain barrierexpressed nodetectable SER-4Ag, whereas
MO outside the blood brain barrier, in the choroid plexus and subfornical organ,
expressed relativelyhigh levels (28). Likewise, the absence ofthe SER4Agon thymic
MO may be related to the presence ofnonleaky endothelium in the cortex of this
organ, creating a "blood-thymus barrier" (36).
It is clear, however, that there are additional mechanisms that regulate the level
ofthe SER-4 Ag, because sinus-lining MO in liver and spleen express intermediate
levels, although they are continuously exposed to plasma. Since these MO popula-
tions are important in the removalofeffete E and since circulating mouse E express
a sialylated ligand for SER (Crocker, P, unpublished observations), ingestion of
effete Eby these MO couldresult ininternalization anddegradationofthe SER4Ag.
The availability of an inhibitory mAb to SER will be a valuable tool in future
studies investigatingthe functional significance ofthe receptor on MO populations.
The distribution ofSER on selected populations ofstromal tissue MO is consistent
with a role incell-cell orcell-matrix interactions. Unlike otherwell-defined MOlectin-
like receptors, such as the mannose and galactose receptors (37, 38), SER does not1344
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mediate phagocytosis of ligand-bearing particles and its primary function is there-
fore unlikely to be related to scavenging. IfSER is involved in adhesive interactions
in tissues such as bone marrow and lymph nodes, it should be possible to identify
ligands on cells that are naturally associated with SER4' stromal MO. Direct sup-
port for this possibility has come from our recent studies in which subpopulations
of mouse bone marrow cells were shown to bind stably to SER+ MOB in a manner
indistinguishable from that of sheep E (Crocker, P., unpublished observations). In
lymph nodes, SER4+ MO in subcapsular sinuses and medullary cords interact with
recirculating lymphocytes and plasma cells, respectively (25), and marginal metal-
lophils of the spleen are thought to bind avidly to B lymphocytes (27).
It is therefore possible that SER contributes to local adhesive interactions that
influence the movement of bone marrow cells and recirculation of lymphocytes. In
addition, the finding that sialic acid binding proteins can be mitogenic for B and
T lymphocytes raises the interesting possibility that SER is involved in growth regu-
lation of attached cells via direct cellular signaling (39, 40).
Summary
An inhibitory rat mAb, SER4, has been raised to the mouse macrophage (MO)-
restricted hemagglutinin, sheep erythrocyte receptor (SER), which binds unopsonized
sheep erythrocytes through recognition of sialylated glycoconjugates. This receptor
was originally defined on mouse resident bone marrow MO where it was implicated
in adhesive interactions of these cells with proliferating hematopoietic cells. In the pre-
sent study using mouse serum-induced thioglycollate-elicited peritoneal MO (TPM)
as a model system for SER expression, mAb SER-4 IgG2a completely blocked ro-
sette formation at 1 Ftg/ml. The inhibition was likely to be via steric hindrance rather
than through a direct interaction with the putative sialic acid binding site of SER
because F(ab')2 and Fab fragments of mAb SER4 gave a maximum inhibition of
50-60% and Oolo respectively, despite binding effectively to the SER4 antigen (Ag).
Immunoprecipitation and Western blotting experiments with cultured MOB or tissue
extracts demonstrated that the Ag recognized by SER4 mAb is a single chain mole-
cule with an apparent Mr by SDS-PAGE of 185 x 103 (reduced) or 170 x 103 (non-
reduced) and is distinct from members ofthe leukocyte common Ag family. Expres-
sion of SER and SER-4 Ag in culture were closely correlated and depended on the
presence of mouse serum for optimal induction. Further evidence that the SER-4
Ag is functionally equivalentto SER was provided by immunocytochemistry in which
the overall pattern of staining in tissues was consistent with previous rosetting ex-
periments . In the bone marrow, expression of the SER4 Ag was restricted to the
resident bone marrow MAD population with no expression on monocytes. High ex-
pression was also observed on stromal MO within the subcapsular sinus and medul-
lary cords in lymph nodes and on marginal metallophils in the spleen. These results
therefore confirm that SER is a novel MO-restricted receptor whose distribution
and properties indicate a role in cellular interactions in hematopoietic and lymphoid
tissues.
Received for publication 28 November 1988.
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